A prospective clinical study on the effectiveness of Phellinus igniarius decoction in treating immune dysfunction in colorectal cancer patients following chemfotherapy
Huihui Zhang, Weihang Li, Die Hu, Wentao Hu, Ting Wang, Panling Xu, Ping Li · 2026
Read A prospective clinical study on the effectiveness of Phellinus igniarius decoction in treating immune dysfunction in colorectal cancer patients following chemfotherapy by Huihui Zhang, Weihang Li, Die Hu, Wentao Hu, Ting Wang, Panling Xu, Ping Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13541534.txt.
Description
Huihui Zhang and colleagues trialed a healing mushroom brew for immune rebound after colon cancer chemo. Published in 2026, the forward-looking random trial took in bowel cancer patients who had finished chemo between January 2021 and June 2024. Chemo often dents immune strength and worsens outlook, yet proof for this fungus brew was thin.
Patients were split 1 to 4 to 1 among dummy pills, mushroom brew, and thymalfasin for eight weeks. The brew group gained helper T cells and natural killer cells, raised attack signals, and lowered swelling signals, while life-quality scores rose. Side-effect rates matched the controls. Patients with a spleen-kidney weakness pattern did best. The authors present the brew as a safe immune aid after chemo, most of all for that pattern.
Catalog record
| CREATOR | Huihui Zhang, Weihang Li, Die Hu, Wentao Hu, Ting Wang, Panling Xu, Ping Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |